AAAAAA

   
Results: 1-8 |
Results: 8

Authors: ROSE C AGAPE P AZZOUZI K MAKHOTINE O DERVITE I MATIS R JOUET JP BAUTERS F
Citation: C. Rose et al., TWIN PREGNANCY IN A PATIENT WITH SICKLE-C ELL DISEASE (S C)/, La Semaine des hopitaux de Paris, 72(9-10), 1996, pp. 315-315

Authors: PREUDHOMME C DERVITE I WATTEL E VANRUMBEKE M FLACTIF M LAI JL HECQUET B COPPIN MC NELKEN B GOSSELIN B FENAUX P
Citation: C. Preudhomme et al., CLINICAL-SIGNIFICANCE OF P53 MUTATIONS IN NEWLY-DIAGNOSED BURKITTS-LYMPHOMA AND ACUTE LYMPHOBLASTIC-LEUKEMIA - A REPORT OF 48 CASES, Journal of clinical oncology, 13(4), 1995, pp. 812-820

Authors: QUESNEL B PREUDHOMME C PHILIPPE N VANRUMBEKE M DERVITE I LAI JL BAUTERS F WATTEL E FENAUX P
Citation: B. Quesnel et al., P16 GENE HOMOZYGOUS DELETIONS IN ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 85(3), 1995, pp. 657-663

Authors: WATTEL E PREUDHOMME C HECQUET B VANRUMBEKE M QUESNEL B DERVITE I MOREL P FENAUX P
Citation: E. Wattel et al., P53 MUTATIONS ARE ASSOCIATED WITH RESISTANCE TO CHEMOTHERAPY AND SHORT SURVIVAL IN HEMATOLOGIC MALIGNANCIES, Blood, 84(9), 1994, pp. 3148-3157

Authors: WATTEL E PREUDHOMME C HECQUET B VANRUMBEKE M QUESNEL B DERVITE I MOREL P FENAUX P
Citation: E. Wattel et al., P53 MUTATIONS ARE ASSOCIATED WITH RESISTANCE TO CHEMOTHERAPY AND SHORT SURVIVAL IN HEMATOLOGIC MALIGNANCIES, Blood, 84(9), 1994, pp. 3148-3157

Authors: QUESNEL B PREUDHOMME C PHILIPPE N DERVITE I DETOURMIGNIES L LAI JL BAUTERS F FENAUX P
Citation: B. Quesnel et al., P16 GENE DELETIONS AND POINT MUTATIONS IN ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND OTHER HEMATOLOGICAL MALIGNANCIES, Blood, 84(10), 1994, pp. 10000299-10000299

Authors: WATTEL E PREUDHOMME C DERVITE I VANRUMBEKE M FLACTIF M LAI JL BAUTERS F FENAUX P
Citation: E. Wattel et al., P53 MUTATIONS, RESPONSE TO CHEMOTHERAPY AND SURVIVAL IN HEMATOLOGICALMALIGNANCIES, Blood, 84(10), 1994, pp. 10000615-10000615

Authors: DERVITE I MOREL P LEPAGE E HUBY X PLANTIER I DETOURMIGNIES L DUPRIEZ B BAUTERS F
Citation: I. Dervite et al., EVALUATION OF RADIOGRAPHIC STUDIES, LACTATE-DEHYDROGENASE (LDH) AND BETA-2-MICROGLOBULIN (B2M) FOR PREDICTING RELAPSE IN PATIENTS WITH AGGRESSIVE LYMPHOMA WHO ACHIEVE A COMPLETE REMISSION (CR) AFTER THE LNH87 REGIMEN, Blood, 84(10), 1994, pp. 10000640-10000640
Risultati: 1-8 |